Statistics
Publications
3
Citations
95
H-Index
3
Active since
2024
T. Semiglazova Yu. is an author at Sun Yat-sen University specializing in metabolic reprogramming in cancer, molecular oncology, and oncology.
Publications per year
2024–2025
3
3
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Jiangjiang Li, T. Semiglazova Yu., Peiting Zeng et al. · Nature Communications · 2024 · 28 citations · Full text
Medicine, Cancer Biology, Oncology +16
1–3 of 3